Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Pulse Biosciences holds a pharmaceutical update conference call » 16:25
02/18/20
02/18
16:25
02/18/20
16:25
PLSE

Pulse Biosciences

$8.12 /

-0.41 (-4.81%)

Management provides an…

Management provides an update on the Company's FDA 510(k) submission for the CellFX System in dermatology on a conference call to be held on February 18 at 5 pm. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Pulse Biosciences holds a pharmaceutical update conference call » 04:55
02/18/20
02/18
04:55
02/18/20
04:55
PLSE

Pulse Biosciences

$8.53 /

-3.68 (-30.14%)

Management provides an…

Management provides an update on the Company's FDA 510(k) submission for the CellFX System in dermatology on a conference call to be held on February 18 at 5 pm. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Pulse Biosciences holds a pharmaceutical update conference call » 08:12
02/14/20
02/14
08:12
02/14/20
08:12
PLSE

Pulse Biosciences

$12.21 /

-1.48 (-10.81%)

Management provides an…

Management provides an update on the Company's FDA 510(k) submission for the CellFX System in dermatology on a conference call to be held on February 18 at 5 pm. Webcast Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Pulse Biosciences downgraded to Neutral from Buy at H.C. Wainwright » 07:13
02/14/20
02/14
07:13
02/14/20
07:13
PLSE

Pulse Biosciences

$12.21 /

-1.48 (-10.81%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Swayampakula Ramakanth downgraded Pulse Biosciences to Neutral from Buy with a price target of $6, down from $26. The analyst downgrades the shares after the company announced the receipt of a Not Substantially Equivalent letter from the FDA in response to its 510(k) application for the CellFX system. Since CellFX is Pulse's only disclosed product, the rejection marks a substantial setback to the company's development and commercialization plans, Ramakanth tells investors in a research note. The analyst believes the news is likely to delay the commercial launch of CellFX by at least 24 months. He expects the stock to remain range bound until the studies are complete.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 18:45
02/13/20
02/13
18:45
02/13/20
18:45
EXPE

Expedia

$110.54 /

-0.35 (-0.32%)

, SVMK

SurveyMonkey

$18.44 /

-0.06 (-0.32%)

, DXCM

DexCom

$253.46 /

+7.41 (+3.01%)

, ROKU

Roku

$139.06 /

+0.82 (+0.59%)

, GDDY

GoDaddy

$70.71 /

-0.15 (-0.21%)

, CC

Chemours

$15.66 /

+0.07 (+0.45%)

, MAT

Mattel

$14.40 /

-0.1 (-0.69%)

, NVDA

Nvidia

$270.81 /

-1.75 (-0.64%)

, TNET

TriNet

$50.59 /

-0.41 (-0.80%)

, SPXC

SPX Corporation

$52.99 /

+1.07 (+2.06%)

, FNF

Fidelity National

$45.20 /

+0.44 (+0.98%)

, NET

Cloudflare

$18.09 /

+0.25 (+1.40%)

, CARG

CarGurus

$34.09 /

-0.36 (-1.04%)

, LPSN

LivePerson

$44.97 /

+0.69 (+1.56%)

, TLND

Talend

$37.57 /

+0.76 (+2.06%)

, ANET

Arista Networks

$238.14 /

+3.74 (+1.60%)

, SWIR

Sierra Wireless

$9.55 /

-0.47 (-4.69%)

, DDOG

Datadog

$48.44 /

-1.55 (-3.10%)

, YELP

Yelp

$36.47 /

+1.12 (+3.17%)

, CGNX

Cognex

$53.55 /

-1.29 (-2.35%)

, ARI

Apollo Commercial

$18.65 /

+0.17 (+0.92%)

, SWAV

ShockWave Medical

$47.71 /

+1.71 (+3.72%)

, AEM

Agnico Eagle

$59.00 /

-0.28 (-0.47%)

, AUY

Yamana Gold

$4.03 /

+0.175 (+4.54%)

, PLSE

Pulse Biosciences

$12.21 /

-1.48 (-10.81%)

UP AFTER EARNINGS:…

UP AFTER EARNINGS: Expedia (EXPE) up 10.2%... SVMK (SVMK) up 8.3%... DexCom (DXCM) up 6.2%... Roku (ROKU) up 5.7%... GoDaddy (GDDY) up 5.6%... Chemours (CC) Up 4.9%... Mattel (MAT) up 4.9%... Nvidia (NVDA) up 4.8%... TriNet (TNET) up 4.3%... SPX Corp (SPXC) up 3.0%... Fidelity National (FNF) up 2.1%... Cloudflare (NET) up 1.5%. DOWN AFTER EARNINGS: CarGurus (CARG) down 17.3%... LivePerson (LPSN) down 17.2%... Talend (TLND) down 12.8%... Arista Networks (ANET) down 9.9%... Sierra Wireless (SWIR) down 6.7%... Datadog (DDOG) down 5.2%... Yelp (YELP) down 5.1%... Cognex Corp (CGNX) down 4.6%... Apollo Commercial Real Estate (ARI) down 4.4%... ShockWave Medical (SWAV) down 2.6%... Agnico Eagle (AEM) down 1.5%... Yamana Gold (AUY) down 1.0%. ALSO LOWER: Pulse Biosciences (PLSE) down 20.4% after disclosing "Not Substantially Equivalent" letter on its CellFX system from FDA. Movers as of 18:30ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pulse Biosciences trading resumes  18:16
02/13/20
02/13
18:16
02/13/20
18:16
PLSE

Pulse Biosciences

$12.21 /

-1.48 (-10.81%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pulse Biosciences receives NSE letter from FDA for CellFX System » 17:45
02/13/20
02/13
17:45
02/13/20
17:45
PLSE

Pulse Biosciences

$12.21 /

-1.48 (-10.81%)

Pulse Biosciences…

Pulse Biosciences announced an update on its FDA submission for the CellFX System. Previously, the company submitted a 510(k) to FDA seeking clearance to commercialize its CellFX System. On February 13, the company received a Not Substantially Equivalent, or NSE, letter from FDA indicating that, based on the data provided, the company has not demonstrated that the CellFX System is substantially equivalent to the predicate device. The company will continue to work with FDA in pursuit of a clearance via a new 510(k) submission and is prepared to provide additional clinical data as required.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Pulse Biosciences trading halted, news pending  10:46
02/13/20
02/13
10:46
02/13/20
10:46
PLSE

Pulse Biosciences

$12.25 /

-1.44 (-10.52%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Solebury Trout to hold an event » 04:55
01/16/20
01/16
04:55
01/16/20
04:55
ACRX

AcelRx

$2.00 /

+0.03 (+1.53%)

, XLRN

Acceleron

$54.29 /

-1.14 (-2.06%)

, AMRN

Amarin

$19.38 /

+0.06 (+0.31%)

, ASMB

Assembly Biosciences

$17.91 /

-0.61 (-3.29%)

, BHVN

Biohaven Pharmaceutical

$51.52 /

-0.475 (-0.91%)

, CASI

Casi Pharmaceuticals

$3.27 /

-0.02 (-0.61%)

, CATB

Catabasis Pharmaceuticals

$6.80 /

+0.16 (+2.41%)

, CPRX

Catalyst Pharmaceuticals

$4.39 /

+ (+0.00%)

, CBMG

Cellular Biomedicine

$17.46 /

-0.03 (-0.17%)

, ENZ

Enzo Biochem

$2.58 /

+0.045 (+1.78%)

, EPGNY

Epigenomics

$0.00 /

+ (+0.00%)

, EPIX

Essa Pharma

$5.69 /

-0.06 (-1.04%)

, EVFM

Evofem

$6.11 /

+0.05 (+0.83%)

, GNFTF

Genfit

$0.00 /

+ (+0.00%)

, GERN

Geron

$1.49 /

+0.055 (+3.83%)

, HCM

Hutchison China MediTech

$28.32 /

-0.01 (-0.04%)

, LCTX

Lineage Cell Therapeutics

$0.74 /

-0.0074 (-0.99%)

, MRKR

Marker Therapeutics

$3.06 /

-0.15 (-4.67%)

, MEIP

MEI Pharma

$2.36 /

+0.16 (+7.27%)

, WVE

Wave Life Sciences

$7.97 /

+0.11 (+1.40%)

, VTVT

vTv Therapeutics

$2.27 /

+0.24 (+11.82%)

, STRO

Sutro Biopharma

$11.83 /

+0.04 (+0.34%)

, SBBP

Strongbridge Biopharma

$2.30 /

+0.02 (+0.88%)

, SELB

Selecta Biosciences

$2.94 /

+ (+0.00%)

, RIGL

Rigel Pharmaceuticals

$2.73 /

+0.115 (+4.40%)

, PLSE

Pulse Biosciences

$14.24 /

+0.2 (+1.42%)

, PTGX

Protagonist Therapeutics

$7.16 /

+0.3 (+4.37%)

19th Annual 1:1…

19th Annual 1:1 Management Access Event will be held in San Francisco on January 13-16.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Solebury Trout to hold an event » 04:55
01/15/20
01/15
04:55
01/15/20
04:55
ACRX

AcelRx

$1.97 /

+0.055 (+2.88%)

, XLRN

Acceleron

$55.43 /

+1.905 (+3.56%)

, AMRN

Amarin

$19.32 /

-0.44 (-2.23%)

, ASMB

Assembly Biosciences

$18.52 /

-0.77 (-3.99%)

, BHVN

Biohaven Pharmaceutical

$51.99 /

+0.09 (+0.17%)

, CASI

Casi Pharmaceuticals

$3.29 /

+0.145 (+4.61%)

, CATB

Catabasis Pharmaceuticals

$6.64 /

+0.09 (+1.37%)

, CPRX

Catalyst Pharmaceuticals

$4.39 /

+0.14 (+3.29%)

, CBMG

Cellular Biomedicine

$17.49 /

+0.07 (+0.40%)

, ENZ

Enzo Biochem

$2.53 /

+0.12 (+4.98%)

, EPGNY

Epigenomics

$0.00 /

+ (+0.00%)

, EPIX

Essa Pharma

$5.75 /

+ (+0.00%)

, EVFM

Evofem

$6.06 /

-0.04 (-0.66%)

, GNFTF

Genfit

$0.00 /

+ (+0.00%)

, GERN

Geron

$1.44 /

+0.09 (+6.69%)

, HCM

Hutchison China MediTech

$28.33 /

+0.9 (+3.28%)

, LCTX

Lineage Cell Therapeutics

$0.75 /

-0.0146 (-1.92%)

, MRKR

Marker Therapeutics

$3.21 /

+0.17 (+5.59%)

, MEIP

MEI Pharma

$2.20 /

+0.1 (+4.76%)

, WVE

Wave Life Sciences

$7.86 /

+0.04 (+0.51%)

, VTVT

vTv Therapeutics

$2.03 /

+0.08 (+4.10%)

, STRO

Sutro Biopharma

$11.79 /

-0.21 (-1.75%)

, SBBP

Strongbridge Biopharma

$2.28 /

+0.05 (+2.24%)

, SELB

Selecta Biosciences

$2.94 /

+0.04 (+1.38%)

, RIGL

Rigel Pharmaceuticals

$2.62 /

+0.445 (+20.51%)

, PLSE

Pulse Biosciences

$14.04 /

-0.99 (-6.59%)

, PTGX

Protagonist Therapeutics

$6.86 /

+0.18 (+2.69%)

19th Annual 1:1…

19th Annual 1:1 Management Access Event will be held in San Francisco on January 13-16.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.